Sawai Pharmaceutical Co., Ltd.
https://www.sawai.co.jp/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sawai Pharmaceutical Co., Ltd.
Towa Follows Suit With Sawai To Steal Japanese Share From Nichi-Iko
Japanese player Towa Pharmaceutical joined Sawai in capitalizing on Nichi-Iko’s misery by taking market share from its rival, as it ran factories at full capacity and plotted for further expansion.
Japan’s Sawai Benefits In Domestic Market From Rivals’ Supply Misery
Sawai was strong in Japan and weak in the US in the first financial quarter of its 2022 financial year, as analysts called on the Japanese firm to improve supply capacity as a “crucial first step towards expanding market share.”
Sawai Lines Up Eight Launches In Japan
Sawai is lining up eight launches as part of the Japanese company’s strategy to capture an increased share of its domestic generics market.
Sawai Lays Out Ten Year Goals Including ¥400bn In Revenues
Japan’s Sawai has laid out its mid- and long-term ambitions in a new company business plan, spanning both its local and overseas operations.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Other Names / Subsidiaries
-
- Cambridge Biotechnology Ltd (CBT)
- Minster Pharmaceuticals
- Proximagen Group
- Upsher-Smith Laboratories Inc.
- Medisa Shinyaku Inc. and Kaken Shoyaku Inc.